76 results
DRS/A
EX-10
CHRS
Coherus Biosciences Inc
24 Sep 14
Draft registration statement (amended)
12:00am
, regulatory investigation or proceeding, administrative hearing or any other similar proceeding pending or to the best of its knowledge threatened … .
SPONSOR represents and warrants that there is no litigation, regulatory investigation or proceeding, administrative hearing or any other similar
8-K
EX-1.1
CHRS
Coherus Biosciences Inc
18 May 23
Other Events
5:02pm
jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation … or paid for, or is currently conducting or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to any Data
8-K
EX-1.1
CHRS
Coherus Biosciences Inc
25 May 18
Coherus Announces Proposed Public Offering of Common Stock
4:01pm
independent investigation and appraisal of the transactions contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company … of, any Environmental Laws, including for the investigation or remediation of any Release or threat of Release of Hazardous Materials, and have no knowledge
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
Documents is subject to ongoing review or outstanding SEC comment or investigation. The Company has made available to Parent true, correct … to them set forth in Section 5.1.
Section 3.10 Litigation. There is no action, suit, claim, arbitration, investigation, inquiry, grievance or other
8-K
EX-2.1
yoni5nqu9f60zt2
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
DRS/A
EX-10
p0ndyil5bw
24 Sep 14
Draft registration statement (amended)
12:00am
425
ti8c v4jwi6
16 Jun 23
Business combination disclosure
7:09am
DRS
EX-10.9
k7rost0s5
4 Aug 14
Draft registration statement
12:00am
425
j6whfjtnqpu4h97vi
16 Jun 23
Business combination disclosure
8:08am
8-K
EX-10.1
6zmtb8i
17 Apr 20
Coherus BioSciences Announces Proposed Convertible Senior Subordinated Notes Offering
4:24pm
DRS
EX-10.7
rf4bl8wwev 57
4 Aug 14
Draft registration statement
12:00am
DRS/A
EX-10
zhjd1t0xf1z65nzi
24 Sep 14
Draft registration statement (amended)
12:00am
8-K
EX-10.1
eee7 zi9lsvga
11 Jan 19
Entry into a Material Definitive Agreement
4:08pm
DRS/A
EX-10
6pq5c
5 Aug 14
Draft registration statement (amended)
12:00am